91 related articles for article (PubMed ID: 25981591)
1. CDH1 germ-line missense mutation identified by multigene sequencing in a family with no history of diffuse gastric cancer.
Lajus TB; Sales RM
Gene; 2015 Sep; 568(2):215-9. PubMed ID: 25981591
[TBL] [Abstract][Full Text] [Related]
2. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
[TBL] [Abstract][Full Text] [Related]
3. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
[TBL] [Abstract][Full Text] [Related]
4. Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer.
São José C; Garcia-Pelaez J; Ferreira M; Arrieta O; André A; Martins N; Solís S; Martínez-Benítez B; Ordóñez-Sánchez ML; Rodríguez-Torres M; Sommer AK; Te Paske IBAW; Caldas C; Tischkowitz M; Tusié MT; ; Hoogerbrugge N; Demidov G; de Voer RM; Laurie S; Oliveira C
Gastric Cancer; 2023 Sep; 26(5):653-666. PubMed ID: 37249750
[TBL] [Abstract][Full Text] [Related]
5. Hereditary diffuse gastric cancer: association with lobular breast cancer.
Schrader KA; Masciari S; Boyd N; Wiyrick S; Kaurah P; Senz J; Burke W; Lynch HT; Garber JE; Huntsman DG
Fam Cancer; 2008; 7(1):73-82. PubMed ID: 18046629
[TBL] [Abstract][Full Text] [Related]
6. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.
Aronson M; Swallow C; Govindarajan A; Semotiuk K; Cohen Z; Kaurah P; Velsher L; Ambus I; Buckley K; Forster-Gibson C; Meschino WS; Blumenthal A; Kim RH; Brar S
Curr Oncol; 2020 Apr; 27(2):e182-e190. PubMed ID: 32489267
[TBL] [Abstract][Full Text] [Related]
7. High-risk individuals' perceptions of reproductive genetic testing for CDH1 mutations.
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2017 Oct; 16(4):531-535. PubMed ID: 28204904
[TBL] [Abstract][Full Text] [Related]
8. A mosaic PIK3CA variant in a young adult with diffuse gastric cancer: case report.
Te Paske IBAW; Garcia-Pelaez J; Sommer AK; Matalonga L; Starzynska T; Jakubowska A; ; van der Post RS; Lubinski J; Oliveira C; Hoogerbrugge N; de Voer RM
Eur J Hum Genet; 2021 Sep; 29(9):1354-1358. PubMed ID: 34075207
[TBL] [Abstract][Full Text] [Related]
9. Diffuse gastric adenocarcinoma during pregnancy and genetic counseling.
Gutiérrez Pérez C; Rodríguez Ledesma I; Blanco Abad C; Catoya Villa JL; Chivato Martín-Falquina I; Cuenca Zarzuela A; López Muñoz AM
Rev Esp Enferm Dig; 2023 Oct; 115(10):580-581. PubMed ID: 36562524
[TBL] [Abstract][Full Text] [Related]
10. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation.
González-Martínez S; Kajabova VH; Pérez-Mies B; Carretero-Barrio I; Caniego-Casas T; Sarrió D; Moreno-Bueno G; Gión M; Perez-García J; Cortés J; Smolkova B; Palacios J
Virchows Arch; 2024 May; ():. PubMed ID: 38713384
[TBL] [Abstract][Full Text] [Related]
11. The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer.
Almeda AF; Grimes SM; Lee H; Greer S; Shin G; McNamara M; Hooker AC; Arce MM; Kubit M; Schauer MC; Van Hummelen P; Ma C; Mills MA; Huang RJ; Hwang JH; Amieva MR; Han SS; Ford JM; Ji HP
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1693-1700. PubMed ID: 35771165
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
13. Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation.
Benusiglio PR; Colas C; Rouleau E; Uhrhammer N; Romero P; Remenieras A; Moretta J; Wang Q; De Pauw A; Buecher B; Stoppa-Lyonnet D; Mouret-Fourme E; Noguès C; Di Maria M; Tlemsani C; Warcoin M; Grandjouan S; Malka D; Caron O; Blayau M
J Med Genet; 2015 Aug; 52(8):563-5. PubMed ID: 26025002
[No Abstract] [Full Text] [Related]
14. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
[TBL] [Abstract][Full Text] [Related]
15. Gene-panel sequencing and the prediction of breast-cancer risk.
Easton DF; Pharoah PD; Antoniou AC; Tischkowitz M; Tavtigian SV; Nathanson KL; Devilee P; Meindl A; Couch FJ; Southey M; Goldgar DE; Evans DG; Chenevix-Trench G; Rahman N; Robson M; Domchek SM; Foulkes WD
N Engl J Med; 2015 Jun; 372(23):2243-57. PubMed ID: 26014596
[No Abstract] [Full Text] [Related]
16. HBOC multi-gene panel testing: comparison of two sequencing centers.
Schroeder C; Faust U; Sturm M; Hackmann K; Grundmann K; Harmuth F; Bosse K; Kehrer M; Benkert T; Klink B; Mackenroth L; Betcheva-Krajcir E; Wimberger P; Kast K; Heilig M; Nguyen HP; Riess O; Schröck E; Bauer P; Rump A
Breast Cancer Res Treat; 2015 Jul; 152(1):129-136. PubMed ID: 26022348
[TBL] [Abstract][Full Text] [Related]
17. upQMPSF, a Method for the Detection of BRCA1 Exon Copy Number Variants.
Azrak S
Biochem Genet; 2015 Jun; 53(4-6):141-57. PubMed ID: 25991562
[TBL] [Abstract][Full Text] [Related]
18. Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.
Kuhlen M; Borkhardt A
Eur J Pediatr; 2015 Aug; 174(8):987-97. PubMed ID: 25982339
[TBL] [Abstract][Full Text] [Related]
19. Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.
Kloth M; Ruesseler V; Engel C; Koenig K; Peifer M; Mariotti E; Kuenstlinger H; Florin A; Rommerscheidt-Fuss U; Koitzsch U; Wodtke C; Ueckeroth F; Holzapfel S; Aretz S; Propping P; Loeffler M; Merkelbach-Bruse S; Odenthal M; Friedrichs N; Heukamp LC; Zander T; Buettner R
Gut; 2016 Aug; 65(8):1296-305. PubMed ID: 26001389
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants and risk of gastric cancer: a pathway analysis of a genome-wide association study.
Lee JH; Kim Y; Choi JW; Kim YS
Springerplus; 2015; 4():215. PubMed ID: 25992311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
